Xero shares (ASX: XRO) has seen sentiment shift dramatically this year, with the latest leg of volatility firmly to the downside. The XRO share price has fallen back close to 30% in less than a month, as a mix of fundamental, technical, and macro pressures took over from what had looked like a promising recovery attempt.
From a late-August high near A$90, Xero shares have now pulled back to A$62.78, a decline of 29.4% in under four weeks. The move is particularly striking given that the A$90 level represented an attempted breakout above the stock’s 200-day SMA, a widely followed technical threshold that, when cleared convincingly, often attracts fresh buying.
Instead, the breakout failed decisively, and what has followed is seemingly a relentless grind lower, with the stock closing in the red in 12 of the past 13 trading sessions. The sheer consistency of the selling points to repositioning by markets, in respomse to a range of overlapping concerns.
Narrower Margins Unsettle Markets
We can look to the recent set of financial results for clues, and whilst they were not catastrophic by any means, there was enough doubt to unsettle a market that had been pricing Xero at a premium.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
The company reported a 27% decline in net profit to NZ$167.4 million, with gross margins contracting meaningfully from 89.0% to 83.9%. Management attributed much of the pressure to costs associated with the ongoing integration of Melio, the US-based business payments platform Xero acquired as part of its push into the North American market.
The margin compression has had a direct impact on forward earnings estimates, with estimates falling from a range of NZ$1.76 to NZ$1.99 down to NZ$1.47 to NZ$1.73. For a stock that had been trading at a price-to-earnings multiple above 60 times, even modest downward revisions carry outsized consequences for valuation.
Despite the near-term headwinds, Xero’s operational growth story remains broadly intact. Total subscribers grew 11% to reach 4.92 million, and management has guided FY27 revenue to land between NZ$3.62 billion and NZ$3.73 billion, implying approximately 30% growth at the midpoint.
The broader macro picture has also done little to help sentiment, with elevated interest rates continuing to weigh on high-multiple, non-dividend-paying technology stocks across the ASX and globally. When the cost of capital remains elevated, the present value of future earnings streams is discounted more aggressively, placing particular pressure on growth-oriented names like Xero that derive much of their investment case from long-dated revenue projections.
Compounding this is a growing conversation around the potential for Generative AI to disrupt traditional cloud accounting and financial management software. While the practical threat remains speculative at this stage, funds have begun trimming exposure to SaaS incumbents where the competitive moat could theoretically be challenged by AI-native alternatives or enhanced offerings from established rivals such as Intuit’s QuickBooks platform.
What Lay Ahead
Despite the drawdown, analysts have remained largely bullish on the stock, with Citi reiterating a Buy rating on the stock with a price target of A$113.60, implying potential upside of approximately 80% from current levels. From a technical standpoint, the stock has moved into oversold territory across several momentum indicators following the 12-session losing streak. While oversold conditions do not guarantee an immediate reversal, they do suggest that the most aggressive phase of the selling may be nearing exhaustion.
Whether the current Xero share price represents a genuine opportunity or merely a pause in a longer corrective move will likely depend on what the company reports next, alongside broader software sentiment that continues to cast a shadow.
